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Deciphering the genetic and epigenetic landscape of pediatric 
bithalamic tumors 
Arnault Tauziède-Espariat1, Marie-Anne Debily2,3, David Castel2,4, Jacques Grill2,4, Stéphanie Puget5, 
Alexandre Roux6, Raphaël Saffroy7, Guillaume Gauchotte8, Ellen Wahler1, Lauren Hasty1, Fabrice 
Chrétien1, Emmanuèle Lechapt1, Volodia Dangouloff-Ros9, Nathalie Boddaert9, Philipp Sievers10,11#, 
Pascale Varlet1# 
1 Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, 75014 Paris, 
France 
2 U981, Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy, Université Paris-Saclay, 
94805 Villejuif, France 
3 Université Evry, Université Paris-Saclay, 91000 Evry, France 
4 Department of Pediatric Oncology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France 
5 Department of Pediatric Neurosurgery, Necker Hospital, APHP, Université Paris Descartes, Sorbonne Paris Cite, 
75015 Paris, France 
6 Department of Neurosurgery, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, 75014 Paris, France 
7 Department of Biochemistry and Oncogenetic, Paul Brousse Hospital, 94804 Villejuif, France 
8 Department of Pathology, CHRU, Nancy, France 
9 Pediatric Radiology Department, Hôpital Necker Enfants Malades, AP-HP, University de Paris, France 
10 Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany 
11 Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), Ger-
man Cancer Research Center DKFZ, Heidelberg, Germany 
# These authors contributed equally to this work. 
Over the past several years, based on the results of the literature: 1) diffuse midline gliomas (DMG) were defined 
as a new tumoral type in the 2016 WHO classification, and 2) four different subtypes are now defined depending 
on their molecular characteristics, and/or locations: DMG H3.3 K27–mutant, DMG H3.1 or H3.2 K27–mutant, 
DMG H3-wildtype with EZHIP overexpression, and DMG EGFR-altered. However, in this rapidly evolving field, a 
more comprehensive analysis of pediatric bithalamic gliomas is needed. We investigated retrospectively data 
from 19 pediatric bithalamic gliomas, confirmed by a central radiological review. We also performed a compre-
hensive clinical, histopathological and molecular evaluation, as well as DNA methylation profiling. 
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Hedgehog-activated anterior skull base meningiomas over- 
express GAB1 
Julien Boetto1,2, Julie Lerond2,3, Matthieu Peyre2,4,5, Suzanne Tran5,6, Pauline Marijon2,4, Michel 
Kalamarides2,4,5, Franck Bielle2,3,5,6,7 
1 Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Hospital Center, Montpellier, 
France 
2 ICM INSERM U1127 CNRS UMR 7225, Paris Brain Institute, Paris, France 
3 SiRIC CURAMUS (Cancer United Research Associating Medicine, University & Society) - site de recherche intégrée 
sur le cancer IUC - APHP.6 - Sorbonne Université, Paris, France 
4 Department of Neurosurgery, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France 
5 Sorbonne Université, UPMC Université Paris 06, Paris, France 
6 Department of Neuropathology, AP-HP, Hôpital Pitié Salpêtrière, Paris, France 
7 Onconeurotek, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France 
Anterior skull base meningiomas were previously showed to have mutations activating the hedgehog (Hh) sig-
nalling pathway. However, identification of Hh-activated tumours is hampered by the lack of a reliable immuno-
histochemical marker. We report GAB1 as a potential immunohistochemical marker of Hh-activated meningio-
mas. GAB1 immunolabeling was compared to SMO mutation detection with Sanger and NGS techniques as well 
as Hh pathway activation study through mRNA expression level analyses in a discovery set of 110 anterior skull 
base meningiomas. We showed that a cut-off score of 250 for the GAB1 expression score (from 0 to 400) lead to 
excellent detection of Hh pathway mutations (sensitivity 100%, specificity 86%). The prospective validation set 
of 21 meningiomas confirmed the excellent negative predictive value of GAB1 expression score. GAB1 immuno-
histochemistry is a fast and cost-efficient tool to screen anterior skull base meningiomas and to facilitate the 
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1p deletion and FGFR1 alterations as specific diagnostic tools to 
discriminate DLGNT from PA in medullary location: an integra-
tive radiological and histomolecular series of 28 cases 
Alice Métais1, Arnault Tauziède-Espariat1, Wael Yacoub2, Thomas Kergrohan3, Raphael Saffroy4, 
Dominique Figarella-Branger5, Emmanuele Uro-Coste6, Annick Sevely7, Delphine Larrieu-Cirron8,9, 
Alexandre Roux10, Sandro Benichi11, Lila Saidoun3, Yassine Bouchoucha12, François Doz12, Volodia 
Dangoulof-Ros2, Jacques Grill3, Pascale Varlet1 
1 Department of Neuropathology, GHU Paris-Psychiatrie and Neurosciences, Sainte-Anne Hospital, Paris, France 
2 Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, Paris, France 
3 Département de Cancérologie de l'Enfant et de l'Adolescent, Institut Gustave Roussy, Université Paris-Sud, 
Villejuif, France 
4 Department of Biochemistry, Paul-Brousse Hospital, Villejuif, France 
5 Department of Pathology and Neuropathology, Timone Hospital, Marseille, France 
6 Département d'Anatomie et Cytologie Pathologiques, CHU de Toulouse, IUCT-Oncopole, Toulouse, France 
7 Department of Radiology, Purpan University Hospital, Toulouse, France 
8 Department of Neurology, Toulouse University Hospital, Toulouse, France 
9 Department of Medical Oncology, IUCT-Oncopole, Toulouse, France 
10 Department of Neurosurgery, GHU Paris-Psychiatrie et Neurosciences Sainte-Anne Hospital, Paris, France 
11 Department of Pediatric Neurosurgery, Hôpital Necker-Enfants Malades, Paris, France 
12 SIREDO Center (Care, Innovation, Research in, Children, Adolescent and Young Adults Oncology), Institut Curie, 
Paris, France 
New tumor types such as diffuse leptomeningeal glioneuronal tumors (DLGNT) have been added to the 2016 
WHO. Their distinction from others intramedullary gliomas is poorly defined. We retrospectively studied a cohort 
of 28 children with low-grade intramedullary tumors. The radiological, histopathological and molecular portrait 
including methylation profiling was established as well oncological treatments data. We observed two main tu-
mor types: DLGNT and pilocytic astrocytomas (PA) that were hardly distinguishable by neuroradiology or histo-
pathology alone. The major criteria to segregate these two tumor types presenting a MAPkinase alteration was 
the 1p deletion. We observed that these tumors interested different populations (infants for PA, school children 
for DLGNT). These tumors evolved insidiously during a long period of time, remission was rarely achieved (5/28). 
Two cases had a deadly evolution. We recommend to systematically assess 1p deletion in intramedullary low-
grade glioma. Improving the management of these diseases remains a major challenge. 
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Classification of pituitary neuroendocrine tumors: Genomic data 
on cell lineage 
Villa C.1,2, Armignacco R.2, Jouinot A.2, Perlemoine K.2, Baussart B.3, Bertherat J.4,2, Gaillard S.3, Assié G. 4,2 
1 Department of Neuropathology, Hôpital de la Pitié-Salpêtrière - APHP Sorbonne Université, 47-83 Bd de l’Hôpital 
75651 Paris, France 
2 INSERM U1016, Institut Cochin, 75014 Paris, France; CNRS UMR 8104, 75014 Paris, France; Université Paris Des-
cartes-Université de Paris, 75006 Paris, France 
3 Department of Neurosurgery, Hôpital de la Pitié-Salpêtrière - APHP Sorbonne Université, 76561 Paris, France 
4 Department of Endocrinology, Center for Rare Adrenal Diseases, Assistance Publique-Hôpitaux de Paris, Hôpital 
Cochin, 75014 Paris, France 
The 2017 World Health Organization (WHO) classification of pituitary adenomas is based on cell lineage and 
transcription factors (TFs). Transcriptome of 134 PitNETs (RNA sequencing) was used to determine TFs expression 
at mRNA level, and to provide a canonical transcriptome signature for each cell-types. Pathological study of the 
present serie of PitNETs included the histological examination and the immunohistochemical tests for all pituitary 
hormones, proliferation markers and TFs including GATA3. 
- Pit1 lineage : based on transcriptome classification, accurate thresholds of immunoexpression for GH, PRL and 
TSH were established in order to define the different Pit-1 subtypes.  
- T-PIT lineage : T-Pit mRNA showed the expected expression in corticotroph PitNETs (35/35),  lower in silent 
ones (Wilcoxon p<10-5).  
- Gonadotroph lineage : SF1 mRNA expression showed the expected high expression in gonadotroph PitNETs 
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Large brain vessel vasculitis in immunocompromised patients 
Isabelle Plu1, Elie Haddad2, Arnaud Fekkar3, Sophie Bonnin4, Natalia Shor5, Valérie Touitou4, Véronique 
Leblond6, Nicolas Weiss7, Eric Caumes2, Sophie Demeret7, Valérie Pourcher2, Danielle Seilhean1 
Sorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles Foix, 75013 Paris, France 
1 Département de Neuropathologie 
2 Service de Maladies Infectieuses et Tropicales 
3 Service de Parasitologie-Mycologie 
4 Service d’Ophtalmologie 
5 Département de Neuroradiology 
6 Service d’Hématologie 
7 Service de Neurologie 
Inflammation of the large arteries of the brain is a relatively rare condition whose best known mechanism is 
hyperimmunity with granulomatous reaction or circulating immune complexes. Some vasculitides are secondary 
to a systemic hyperimmune disease or to an infectious disease (purulent or tuberculous meningitis). We describe 
here the occurrence of cerebral infarcts in three immunocompromised patients with neutrophilic aseptic men-
ingitis. The MRI appearance was vasculitis of the anterior cerebral arteries (one case) or basilar arteries (two 
cases). PCR found Aspergillus fumigatus in the CSF two days before a positive cavum biopsy in one case. In the 
other two cases, Aspergillus fumigatus was found postmortem. The neuropathologic appearance was that of 
filament-rich necrotizing arteritis. There was no other organ involvement. These observations highlight a proba-
bly underestimated cause of central nervous system arteritis whose curability relies on early diagnosis based on 
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Cerebellar ataxia with neuropathy and vestibular areflexia syn-
drome (CANVAS): a case report 
Susana Boluda1, David Grabli2, Vincent Huin3, Giulia Coarelli4, Alexandra Durr4, Danielle Seilhean1 
1 Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Laboratoire Neuro-
pathologie Raymond Escourolle, Hôpital de la Pitié Salpêtrière, Paris, France 
2 AP-HP, Pitié Salpêtrière University Hospital, Department of Neurology, Sorbonne University, Paris, France 
3 Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS; University of Lille, Univ. Lille, 
Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neuroscience & Cognition, Lille, France 
4 Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Genetics Department, 
Hôpital de la Pitié Salpêtrière, Paris, France 
CANVAS is a rare disease characterized by an intronic biallelic AAGGG expansion in RFC1. We report the case of 
a 74-year-old man who presented with cramps, mixed sensory and cerebellar ataxia, vestibular areflexia and 
neuropathic pain in addition to parkinsonian symptoms. Macroscopic examination showed atrophy of the cere-
bellar vermis and pallor and atrophy of the posterior columns. Microscopic examination revealed, in addition to 
diffuse Lewy body pathology, axonal loss in the dorsal columns and a moderate loss of Purkinje cells in the cere-
bellum.  There was marked astrocytic gliosis in contact with the dendrites in the spinal cord and molecular layer 
of the cerebellum as well as disorganization of the radial glia in the cerebellum. We report the first complete 
neuropathological examination of the brain and spinal cord of an RFC1 patient and describe astrocytic abnormal-









Copyright: © 2021 The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited, a link to the Creative Commons license is provided, and any changes are 
indicated. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. 
 
Free Neuropathol 2:32:9 
 
Neuropathological and amyloid peptide differences between 
Down syndrome and familial Alzheimer’s disease with duplica-
tions and missense mutations in APP gene 
Amal Kasri1, Léa Durix1, Susana Boluda1,2, Lev Stimmer1, Eleni. Gkanatsiou3, Gunnar Brinkmalm3, Yannick 
Vermeiren4,5, Sarah E. Pape6, Peter P. De Deyn4,5, Charles Duyckaerts1,2, Henrik Zetterberg3,7, Andre 
Strydom6, Marie-Claude Potier1 
1 Paris Brain Institute, ICM, CNRS UMR7225 - INSERM U1127 – UPMC, Paris, France 
2 Laboratoire de Neuropathologie R Escourolle, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France 
3 Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothen-
burg, Sweden 
4 Department of Biomedical Sciences, Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, 
Antwerp, Belgium 
5 Department of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen 
(UMCG), Groningen, Netherlands 
6 Institute of Psychology and Neuroscience, King’s College London, 16 De Crespigny Park, London, United Kingdom 
7 Sahlgrenska University Hospital, Clinical Neurochemistry Laboratory, Mölndal, Sweden 
Cerebral Amyloid Angiopathy (CAA) is present in 80% of Alzheimer's disease (AD) patients. However, CAA is more 
prominent in familial cases with APP mutations or duplications (DUPAPP) and in individuals with Down syndrome 
(DS). In order to explain these differences, we investigated the alterations in the endo-lysosomal pathway, Aβ 
species and CAA grading in post-mortem human brain tissues. Using immunohistochemistry, we identified in-
creased Rab5 puncta size in all cases except those with APP mutations compared to controls. Moreover, we 
found elevated levels of Aβ40 but not Aβ42 in DUPAPP and in DS correlating with CAA grading. Altogether, these 
results suggest that CAA arises from specific accumulation of Aβ40 species or, alternatively, that Aβ40 is the 
principal Aβ species produced in DUPAPP and DS and is more prone to aggregation in blood vessels. The ongoing 
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Characterization of the endolysosomal compartment of nora-
drenergic neurons of the locus cœruleus in neurodegenerative 
diseases 
Marta Fructuoso1, Susana Boluda1,2, Lev Stimmer1, Yannick Vermeiren3, Peter P. De Deyn3, Debby Van 
Dam3, Andre Strydom4, Charles Duyckaerts1,2, Marie-Claude Potier1 
1 ICM Institut du Cerveau et de la Moelle épinière, CNRS UMR7225, INSERM U1127, UPMC, Hôpital de la Pitié-
Salpêtrière, 47 Bd de l’Hôpital, Paris, France 
2 Laboratoire de Neuropathologie R Escourolle, Hôpital de la Pitié-Salpêtrière, AP-HP, 75013 Paris, France 
3 Department of Neurology and Alzheimer Center, University Medical Center Groningen, University of Groningen, 
Groningen, The Netherlands. Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences, 
Institute Born-Bunge, University of Antwerp, Antwerp, Belgium 
4 Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology & Neuroscience, 
King's College London, London, UK 
Degeneration of the locus coeruleus (LC) is a common feature in Parkinson's disease (PD), Alzheimer's disease 
(AD), and Down syndrome (DS). LC is the main source of noradrenaline in the brain, and neuronal loss in this 
nucleus is associated with dementia. Endolysosomal abnormalities may contribute to the accumulation of toxic 
proteins. We hypothesize that this could be one mechanism of LC neurons vulnerability (JPND-HEROES, www.he-
roes-jpnd.eu). Using post-mortem paraffin fixed LC of control and pathological cases, we confirm the presence 
of Aβ plaques and P-tau in AD and DS brains, and Lewy bodies in PD samples. Analysis of confocal microscopy 
images of immunofluorescence revealed that area of the Rab5 positive puncta of endosomes was increased in 
AD whereas the area Cathepsin B positive puncta of lysosomes was reduced in PD. Our results suggest that en-
dolysosomal alterations could be a mechanism implicated in the degeneration of noradrenergic neurons, and 
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Neuropathology analysis as a precious tool to ascertain the path-
ogenicity of nearsplice / intronic variants in Amyotrophic Lateral 
Sclerosis: example of a SOD1 nearsplice / intronic mutation 
François Muratet1, Elisa Teyssou1, Aude Chiot1, Séverine Boillée1, Christian S. Lobsiger1, Delphine Bohl1, 
Beata Gyorgy1, Justine Guegan1, Yannick Marie1, Maria-Del-Mar Amador1,2, François Salachas1,2, Vincent 
Meininger3, Emilien Bernard4,5, Jean-Christophe Antoine6, Jean-Philippe Camdessanché6, William Camu7, 
Cécile Cazeneuve8, Anne-Laure Fauret-Amsellem8, Eric Leguern1,8, Kevin Mouzat9, Claire Guissart9, Serge 
Lumbroso9, Philippe Corcia10,11, Patrick Vourc’h11,12, Aude-Marie Grapperon13, Shahram Attarian13, Annie 
Verschueren13, Danielle Seilhean1,14* and Stéphanie Millecamps1* 
1 CM, Institut du Cerveau, Inserm U1127, CNRS UMR7225, Sorbonne Université, Paris, France 
2 AP-HP, Département de Neurologie, Centre de référence SLA Ile de France, Hôpital de la Pitié-Salpêtrière, Paris, 
France 
3 Hôpital des Peupliers, Ramsay Générale de Santé, Paris, France 
4 Centre de Référence SLA, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Université de Lyon, 
Bron, France 
5 Institut NeuroMyoGène, CNRS UMR5310, INSERM U1217, Faculté de Médecine Rockefeller, Université Claude 
Bernard Lyon I, Lyon, France 
6 Service de Neurologie, Centre de Ressource et de Compétence SLA, Hôpital Nord, CHU de Saint-Etienne, Saint-
Etienne, France 
7 Centre de référence SLA, Hôpital Gui de Chauliac, CHU et Université de Montpellier, Montpellier, France 
8 Département de Génétique et Cytogénétique, Unité Fonctionnelle de Neurogénétique Moléculaire et Cellulaire, 
APHP, Hôpital Pitié-Salpêtrière, Paris, France 
9 Laboratoire de Biochimie et Biologie Moleculaire, CHU Nimes, Nîmes, Motoneuron Disease: Pathophysiology and 
Therapy, INM, INSERM, Univ. Montpellier, Montpellier, France 
10 Centre SLA, CHU Tours, Tours, France 
11 UMR 1253, Université de Tours, Inserm, Tours, France 
12 Service de Biochimie et Biologie Moléculaire, CHU Tours, Tours, France 
13 Centre de Référence pour les Maladies Neuromusculaire et la SLA, CHU de Marseille, Hôpital de la Timone, Mar-
seille, France 
14 AP-HP, Département de Neuropathologie, Hôpital Pitié-Salpêtrière, Paris, France 
* Equal contribution 
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Among etiologic factors assumed to be responsible of Amyotrophic Lateral Sclerosis (ALS), several plausible caus-
ative genes have emerged. It becomes crucial to determine the pathogenicity of any genetic variant identified 
through whole exome/genome sequencing analysis, including those located in non-coding regions. We describe 
a c.358-10T>G nearsplice/intronic variant in the SOD1 gene, encoding superoxide dismutase 1, as the second 
prominent mutation among the SOD1 related-French ALS families. This variant leads to the addition of three 
amino acids in the protein sequence and impairs the protein secondary structure. Biochemical and neuropatho-
logical analyses performed on patient tissue revealed massive cytoplasmic SOD1 and neurofilament accumula-
tion in spinal motor neurons, similar to those observed in spinal cord of patients with D83G or G93D SOD1 mu-
tations. These neuropathology findings ascertain this variant pathogenicity, which is a crucial information in the 
context of patient enrolment in ongoing clinical trials targeting SOD1 by antisense oligonucleotides. 
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Implication of microglial cells and peripheral macrophages in 
Amyotrophic Lateral Sclerosis (ALS) 
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In mouse models of Amyotrophic Lateral Sclerosis (ALS), the most common motor neuron (MN) disease of the 
adult, microglial cells/ macrophages have been shown to participate to disease progression. However, the re-
spective contributions of microglial cells (MG) and peripheral macrophages (PM) were not documented. We have 
now shown that PM were present around MN axons of ALS patients, both in motor roots and peripheral nerves. 
In ALS mice, PM were progressively activated and their infiltration into the spinal cord was very limited and dis-
ease-length dependent. Transcriptomics analysis showed that MG and PM reacted differently to MN degenera-
tion. Replacing PM by macrophages more neurotrophic, at disease onset, increased ALS mouse survival and 
downregulated not only PM activation in peripheral nerves but also suppressed proinflammatory responses of 
MG in the spinal cord, with a switch toward neuronal support. Thus, targeting PM, directly at the periphery, could 
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The Neuro-CEB brainbank: a brief history (15 years! ) of neuropa-
thology 
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Lille, France), David Meyronet (Hôpital Pierre Wertheimer, Lyon, France), Isabelle Plu (GH Pitié-Salpêtrière, Paris, 
France), Valérie Rigau (Hôpital Gui de Chauliac, (Montpellier, France) 
6 Laboratoire de Neuropathologie, GH Pitié-Salpêtrière, AP-HP-Sorbonne Université, Paris, France 
The Neuro-CEB national brainbank was founded in 2006 at the initiative of patients’ associations, to support a 
post mortem brain donation program. The missions are to collect, sample, prepare and store nervous tissues 
(brain and spinal cord), taken post mortem from "control" subjects (not suffering from neurological diseases) 
and from patients suffering from Alzheimer or Parkinson disease, multiple sclerosis, ataxia, amyotrophic lateral 
sclerosis, frontotemporal lobar degeneration, or Cadasil. The biological ressources are provided to research 
teams presenting a suitable project reviewed by a scientific committee. The organization relies on a network of 
neuropathologists from 14 hospitals. They are in charge of brain sampling and neuropathological diagnosis. The 
expertise of these neuropathologists ensures a high quality of the samples. Their involvement over the past 15 
years alongside research teams, has led to the publication of more than 100 scientific articles. This illustrates the 
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Human Brain Imaging with STochastic Optical Reconstruction 
Microscopy (STORM) 
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The recent development of STochastic Optical Reconstruction Microscopy (STORM) has contributed to major 
advances in Neuroscience. However this technique is restricted to cultured cells and rodent brain, and no exper-
iment on human samples has been reported so far. To this end, we combined cellular microscopy protocols with 
neuropathology tissue preparation techniques to characterize physiological and pathological structures in brain 
samples with 2D-, 3D- and two-color STORM. This approach proved to be particularly effective at visualizing the 
organization of dense protein inclusions in samples from patients affected with neurodegenerative diseases. 
These very first results open further gates to a more comprehensive understanding of the human brain organi-
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AI applied in neuropathology: automated detection of intraepi-
dermal nerve fibers for the diagnosis of small-fiber neuropathies 
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The measurement of intra-epidermal nerve fiber density (IENFD) in skin biopsy is the gold standard for the diag-
nosis of small fiber neuropathy (SFN). This recently described entity causes neuropathic pain and dysautonomia. 
Numerous etiologies are described, although the majority of them remain idiopathic. The classic DFNIE reading 
method, derived from a 3mm punch biopsy and 50 micron sections, is based on the anti-PGP9.5 labelling with a 
visual count related to the analyzed length, a long process thus slowing down its development. Thanks to the 
digitization of the double-labeled slides in immunofluorescence anti-PGP9.5 and anti-coll IV since 2012 allowing 
the computer labeling of the traversing fibers, we were able to train an automated reading algorithm which 
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Histological description of myopathy related to chronic graft ver-
sus host disease and characterization of inflammatory infiltrate 
by imaging mass cytometry 
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Chronic graft versus host disease (cGvHD) is a long-term side effect of allogenic hematopoietic cells transplanta-
tion, affecting muscles in 3,4 to 7,7% of patients. This study proposes a complete histological and immunohisto-
logical description of myopathy in the context of cGvHD and a characterization of the inflammatory infiltrate by 
imaging mass cytometry technology (IMC). Histological description was performed on 19 patients and divided 
patients into three groups: 10 patients with no fiber necrosis and no or very low inflammatory infiltrate, 6 pa-
tients with fiber necrosis and high inflammatory infiltrate and 3 patients with fasciitis. All patients had variations 
in fiber size, diffuse MCH-I and perifascicular MCH-II immunostaining. 7 patients were analyzed by IMC. The main 
inflammatory population was macrophage cells, but eosinophils represented more than 5% of inflammatory cells 
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Highlighting autophagy in a fatal case of Pompe’s disease 
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Pompe’s disease is a rare autosomal recessive disorder caused by mutations in the acid α-glucosidase (GAA) 
gene. Alpha-glucosidase deficit leads to lysosomal and non-lysosomal accumulation of glycogen with different 
forms of the disease, ranging from early-onset to late-onset form (LOF). 
We report the case of a LOF treated by enzyme replacement therapy (ERT), who died of myocardial infarct. We 
describe expression of several lysosomal and autophagy markers in several tissues. We observed a glycogen-
accumulation in brain, associated to increased expression of p62, LC3A/B and LAMP-2 localized in the neocortex 
and hippocampus. Both neurons and glial cells were affected, however cerebral vessels were normal. Similar 
results were observed in muscle, heart and liver. Our data suggest that autophagy impairment could be an im-
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Diagnosis and classification of peripheral nerve vasculitis: at-
tempt at simplification bases on a retrospective study at Limoges 
University Hospital between 2014 and 2020 
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Peripheral nerve vasculitis remain rare and challenging to diagnose. We tried to simplify criteria of the PNS 2010 
by searching for those strongly associated with certain and probable vasculitis, and to propose a management of 
the biopsy. This retrospective study included 46 patients with definite and probable vasculitis according to the 
criteria of the PNS 2010 who underwent neuromuscular biopsy and 21 controls (neurolymphomatosis and CIDP). 
Clinical, biological and pathological features were collected. Criteria discriminating vasculitis from controls were 
asymmetry, axonal involvement, biological inflammation, T cells in vessel wall, and nerve haemosiderin deposits. 
Two criteria distinguish definite and probable vasculitis: ovoid and endoneurial haemosiderin deposits. The tech-
niques useful for pathological diagnosis are serial cuts, typing of inflammatory elements and Perls staining. We 
proposed a slightly simplified classification of vasculitis according to the PNS 2010 and a management of neuro-
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Experimental evaluation of myosuppressive effects of IFN-
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Dysimmune and Inflammatory Myopathies (DIMs) are acquired idiopathic myopathy associated with immune 
response dysregulation. Inclusion Body Myositis (IBM), the most common DIMs, is characterized by endomysial 
infiltrates of cytotoxic T lymphocytes CD8, muscle type II-interferon (IFNγ) signature, and by the lack of response 
to immunomodulatory therapies. We showed that IBM differs from other myopathies by the presence of chronic 
degenerative myopathic features including the altered functions of skeletal muscle stem cells. Here, we demon-
strated that, in vitro, protracted IFNγ treatment inhibits the activation, proliferation, migration, differentiation, 
and fusion of myogenic progenitor cells and promotes their senescence through JAK-STAT-dependent activation. 
JAK-STAT inhibitor, ruxolitinib abrogates the deleterious effects of IFNγ, In conclusion, our results indicate that 
IFNγ could impair muscle regeneration in the context of inflammatory myopathies and that JAK inhibitors could 
represent interesting therapies for immune myopathies with IFNγ signature. 
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